Global Immunoassay Market

Global immunoassay market by product (reagent & kits, analyzers, software & services), by technology (chemiluminescence immunoassays (CLIA), fluorescence immunoassays (FIA), radioimmunoassay (RIA), rapid test, others), by application (autoimmune disease, cardiology, endocrinology, infectious disease testing, oncology, therapeutic drug monitoring, others), by end user (academia, blood banks, clinical laboratories, hospitals, pharmaceutical & biotech companies, others), by region (Asia Pacific, Europe, North America, Rest of the World (RoW)), industry snapshot, 2022-2028

SKU: GH02104I Category: Region:

USD1,250.00

Description

An immunoassay is a test that relies on biochemistry to measure the presence and/or concentration of an analyte. The analyte can be large proteins, antibodies that a person has produced as a result of an infection or small molecules. The global immunoassay market size is projected to grow by USD 9 billion from 2022 to 2028, registering a CAGR of 6.1 percent, according to a new report by Gen Consulting Company.

This industry report offers market estimates of the global market, followed by a detailed analysis of the product, technology, application, end user, and region. The global market data on immunoassay can be segmented by product: reagent & kits, analyzers, software & services. The reagent & kits segment was the largest contributor to the global immunoassay market in 2021. Immunoassay market is further segmented by technology: chemiluminescence immunoassays (CLIA), fluorescence immunoassays (FIA), radioimmunoassay (RIA), rapid test, others. Based on application, the immunoassay market is segmented into: autoimmune disease, cardiology, endocrinology, infectious disease testing, oncology, therapeutic drug monitoring, others. On the basis of end user, the immunoassay market also can be divided into: academia, blood banks, clinical laboratories, hospitals, pharmaceutical & biotech companies, others. Immunoassay market by region is categorized into: Asia Pacific, Europe, North America, Rest of the World (RoW).

The global immunoassay market is highly competitive. Key companies profiled in the report include Abbott Laboratories, Becton Dickinson and Company, bioMerieux Inc., Bio-Rad Laboratories Inc., Danaher Corporation (Beckman Coulter Inc.), DiaSorin S.p.A., F. Hoffmann-La Roche AG, Meril Life Sciences Pvt. Ltd., Ortho Clinical Diagnostics Holdings plc, Quidel Corporation, Randox Laboratories Ltd., Siemens Healthineers AG, Sysmex Corporation, Thermo Fisher Scientific Inc.

The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.

Why buy this report?
– Get a detailed picture of the Global Immunoassay Market
– Identify segments/areas to invest in over the forecast period in the Global Immunoassay Market
– Understand the competitive environment, the market’s leading players
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.
Interested in this report? Get your FREE sample now!
Global Immunoassay Market

Please fill out our form and we will get back to you.